Barinthus Biotherapeutics (BRNS) Debt to Equity (2021)
Barinthus Biotherapeutics' Debt to Equity history spans 1 years, with the latest figure at $0.0 for Q4 2021.
- For Q4 2021, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Dec 2021 reached $0.0, changed N/A, while the annual FY2021 figure was $0.0, N/A changed from the prior year.
- Debt to Equity reached $0.0 in Q4 2021 per BRNS's latest filing.
- In the past five years, Debt to Equity ranged from a high of $0.0 in Q4 2021 to a low of $0.0 in Q4 2021.